News & Perspective

Oct 08, 2008

Oct 08, 2008

Two firms win NIAID support for Ebola-Marburg vaccines

(CIDRAP News) – Two biotechnology companies—Crucell, based in the Netherlands, and Integrated BioTherapeutics, based in Germantown, Md.—recently announced that they have received $30 million and $22 million contracts, respectively, from the National Institutes of Allergy and Infectious Diseases (NIAID) to develop single vaccines that would protect against both Ebola and Marburg viruses.

Oct 22, 2008

Oct 22, 2008

GAO says tighter security needed at two BSL-4 labs

(CIDRAP News) – Two of the nation's five biosafety level 4 (BSL-4) labs lack outer-ring security controls to protect against a terrorist attack or theft of some of the world's most dangerous pathogens, such as the Ebola and smallpox viruses, according to a new report from the Governmental Accountability Office (GAO).